NCT06270524View on ClinicalTrials.gov

Study of the C5a/C5aR1 Axis in IgG4-associated Disease: a Potential Therapeutic Target

NANot yet recruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

September 1, 2026

Study Completion Date

April 30, 2027

Conditions
Immunoglobulin G4-Related Disease
Interventions
PROCEDURE

Blood sampling

Blood sampling will be taken for further analysis

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT06270524 - Study of the C5a/C5aR1 Axis in IgG4-associated Disease: a Potential Therapeutic Target | Biotech Hunter | Biotech Hunter